CClinicalTrials.gg
RecruitingNCT04559373Updated Oct 7, 2026

Virtual Reality and Field Training to Enhance Community Walking After Stroke

An interventional study of Virtual Reality and Field Training (VRFT) in Stroke, sponsored by McGill University. Recruiting at 2 sites in Canada. Open to participants aged 40 Years to 74 Years. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by McGill University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Apr 2021; still recruiting 5 years 6 months later.
Updated Oct 7, 2026Primary completion movedStudy completion movedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
40 Years to 74 Years
Sex
All
01

Study summary

While stroke survivors discharged from rehabilitation present with some recovery in mobility, their ability to ambulate in the community remains limited. The investigators propose to test a novel, low-cost, intensive and individually tailored intervention that combines virtual reality (VR) and field training to enhance community ambulation and participation in stroke survivors discharged from rehabilitation.

The aims are to: (1) Assess feasibility, acceptability, safety and adherence of the intervention in stroke survivors; and (2) Examine the extent to which post-intervention changes in functional walking and participation to community walking vary according to walking, cognitive and visual-perceptual abilities.

The investigators will use a virtual environment prototype simulating a shopping mall and surrounding streets, in which participants will interact using VR goggles and game controllers. Scenarios of increasing levels of complexity will be introduced. This intervention study involves a single group, multiple pre- multiple post- study design where chronic stroke participants will engage in a 4-week training program. The program will include VR training sessions performed in the clinical setting (3/week) and practice of community ambulation skills while supervised by family/caregivers (2/week). Participants will be assessed on measures of functional walking, balance \& mobility and participation to community walking. Adherence, safety and acceptability will be documented. This study will generate foundation knowledge on the response to the intervention based on individual capacities.

Read the detailed description

Ambulating in community environments requires the skills to cope with multiple, simultaneous dimensions such as walking speed and distance, etc. Such skills remain compromised in the majority of stroke survivors due to insufficient or lack of targeted practice. The investigators propose to test a new, individually-tailored intervention, developed by the research team, grounded in best evidence in community ambulation, principles of motor learning and participatory action research. This unique intervention will combine virtual reality (VR) and field training practice to optimize learning that can be generalized to daily walking activities.

Participants will engage in the 4-week, individually-tailored intervention that comprises of supervised VR training sessions (3 times/week) performed in the clinical setting. VR sessions will be completed by field training assignments. Subjects will be assessed twice prior to the intervention, immediately after the intervention and at follow up.

Generalized estimating equations will be used to compare changes in main and secondary outcomes across time points, with each personal factor of interest (e.g. walking capacity, visual-perceptual function, and cognitive function) analyzed individually while adjusting for age. Outcomes on adherence, safety and acceptability will be analyzed with descriptive statistics.

Required sample size was estimated based on Green's rule (effect size=0.5, power=80%, α=0.05) with a variance inflation factor assuming moderate within-subject correlations for 3 post-baseline measurement time points. This yields a sample size of 30. Assuming a worst-case scenario of 30% attrition rate, a total of 40 stroke subjects (20/site) will be recruited.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Aging
  • Biomechanics
  • Community ambulation
  • Intervention
  • Locomotion
  • Rehabilitation
  • Sensorimotor integration
  • Virtual reality
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,013 are open to participants now.

This study's planned enrollment of 40 is below the median of 50 across 5,366 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

McGill University is the lead sponsor of 244 studies on the registry; 49 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 74 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

People with chronic stroke and persistent deficits in walking / visual-perceptual / cognitive capacities. They can be male or female, aged from 40 to 74 years, with normal/corrected visual and auditory acuity, and present with:

  • First-ever supratentorial unilateral stroke 9-24 months ago (such chronicity will ensure steady-state mobility without long-term disuse-related changes
  • Mild-to-moderate hemiparesis (Chedoke McMaster Stoke Assessment stages 4/7-6/7 on postural control, leg \& foot)
  • Ability to walk independently with/without walking aids for at least 1 min at 0.4-0.9 m/s (such a speed range indicates mobility not sufficient for functional community ambulation: shopping \~1.1m/s, street crossing \~1.2 m/s)
  • Intact or mildly affected cognitive function (Montreal Cognitive Assessment scores ≥ 22/30)
  • Intact to moderately affected visual-perceptual function (positive scores on a maximum of 3/6 tasks on the Behavioural Inattention Test)

Exclusion criteria

Exclusion Criteria:

  • Subjects with comorbidities interfering with walking
  • Subjects with comorbidities interfering with visual perception
  • Subjects without medical clearance for exercise
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Virtual Reality and Field Practice Training (VRFT)

    Participants will engage in a 4-week VRFT intervention that comprises of 1-hour training sessions, 3 times/week.

    Other: Virtual Reality and Field Training (VRFT)

Interventions

  • OtherVirtual Reality and Field Training (VRFT)

    The VRFT intervention involves the intensive practice of community ambulation skills. Some of the training sessions will be performed in a virtual environment, while others will consist of field training exercises in the community. During the intervention, stroke participants will be invited to practice different dimensions of community ambulation, such as postural transitions, avoiding other pedestrians, dual-task walking, etc.

06

What researchers measure

Primary outcomes

  1. Post-intervention change in the Six Minute Walk Test (6MWT)

    The six-minute walk test measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes. The individual is allowed to self-pace and rest as needed as they traverse back and forth along a marked walkway.

    Time frame: Pre-intervention (Week4) and post-intervention (Week8)

  2. Change in the Six Minute Walk Test (6MWT) at Follow-up

    The six-minute walk test measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes. The individual is allowed to self-pace and rest as needed as they traverse back and forth along a marked walkway.

    Time frame: Post-intervention (Week8) and Follow-up (Week12)

Secondary outcomes

  1. Dynamic Gait Index

    Developed to assess the likelihood of falling in older adults

    Time frame: Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)

  2. 5m Walk Test

    Assesses walking speed in meters per seconds over a short duration

    Time frame: Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)

  3. Activities-Specific Balance Confidence Scale

    16-item self-reported measure of balance confidence performing various activities without losing balance or experiencing a sense of unsteadiness. Items are rated on a 0%-100% response scale, with a score of 0 representing no confidence and a score of 100 representing complete confidence.

    Time frame: Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)

  4. Trip Activity Log

    Questionnaire to record the number of trips and walking-related activities in the community (e.g. outside home) 3 days preceding its administration

    Time frame: Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)

  5. Environmental Analysis of Mobility Questionnaire

    Self-reported tool to assess mobility problems due to the environment

    Time frame: Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)

  6. Assessment of Life Habits (Life-H: mobility and community life domains)

    Assesses mobility and community life habits based on the levels of accomplishment and assistance required as well as satisfaction

    Time frame: Baseline (Week0), pre-intervention (Week4), post-intervention (Week8) and follow-up (Week12)

Other outcomes

  1. Adherence to intervention

    Training logbook filled by researchers/clinicians (virtual reality) and subjects (field training) component)

    Time frame: 3x/week over the 4-week intervention for the virtual reality component; 2x/week over the 4-week intervention for the field training component

  2. Safety of the intervention

    Assesses by systematically collecting any occurrence of adverse/unwanted events (falls, injuries, fatigue, etc).

    Time frame: 3x/week over the 4-week intervention of the virtual reality component

  3. Acceptability of the intervention

    Assesses using the Technology Acceptance Model based Questionnaire (Tam-Q) based on the technology acceptance model, in which subjects will rate their perception on each dimension using a visual analog scale ranging from 0-56, with higher score representing higher acceptance to the intervention.

    Time frame: Post-intervention (Week8)

  4. Cadence

    Cadence is the rate at which a person walks (steps per minute) and will be measured with the GaitRite system.

    Time frame: Pre-intervention (Week4) and post-intervention (Week8)

  5. Step length

    Step length is the distance (in meters) from a point of contact with the ground of one foot to the following occurrence of the same point of contact with the other foot and will be measured with the GaitRite system.

    Time frame: Pre-intervention (Week4) and post-intervention (Week8)

  6. Step duration

    Step duration is the period of time (in seconds) taken for one step is measured from an event of one foot to the following occurrence of the same event with the other foot and will be measured with the GaitRite system.

    Time frame: Pre-intervention (Week4) and post-intervention (Week8)

  7. Stance phase

    Stance phase is the period of time when the foot is in contact with the ground (%) and will be measured with the GaitRite system.

    Time frame: Pre-intervention (Week4) and post-intervention (Week8)

  8. Swing phase

    Swing phase is the period of time when the foot is not in contact with the ground (%) and will be measured with the GaitRite system.

    Time frame: Pre-intervention (Week4) and post-intervention (Week8)

07

Study locations

1 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data for all primary and secondary outcome measure will be made available.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Primary completion
May 31, 2026→May 31, 2027
Oct 7, 2026
Study completion
Dec 31, 2026→Dec 31, 2027
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    Primary completion May 31, 2026→May 31, 2027
    Study completion Dec 31, 2026→Dec 31, 2027
    + 1 other change: contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04559373
Lead sponsor
McGill University
Collaborators
Jewish Rehabilitation Hospital, Integrated University Health and Social Services Center of the Capitale-Nationale, Laval University
Responsible party
Anouk Lamontagne (Associate Professor, McGill University) — Principal investigator
First posted
Sep 22, 2020
Start date
Apr 1, 2021
Primary completion
May 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Oct 7, 2026

Study contacts

Anouk Lamontagne, PhD
Contact
anouk.lamontagne@mcgill.ca
514-938-4397
Andréanne Blanchette, PhD
Contact
andreanne.blanchette@fmed.ulaval.ca
418-656-2131 ext. 403579
Anouk Lamontagne, PhD
principal investigator · McGill University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion